Comments

Implications of the EHA/ELN guidelines for reporting blast percentage. Comment on: "Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel"

From the US Food and Drug Administration, Silver Spring, MD
From the US Food and Drug Administration, Silver Spring, MD
Haematologica Early view Apr 2, 2026 https://doi.org/10.3324/haematol.2026.300842